Cargando…

The Value-of-Information and Value-of-Implementation from Clinical Trials of Diagnostic Tests for HIV-Associated Tuberculosis: A Modeling Analysis

Objectives. Conventional value-of-information (VOI) analysis assumes complete uptake of an optimal decision. We employed an extended framework that includes value-of-implementation (VOM)—the benefit of encouraging adoption of an optimal strategy—and estimated how future trials of diagnostic tests fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Pamela P., Fitzmaurice, Kieran P., Le, Mylinh H., Panella, Christopher, Jones, Michelle L., Pandya, Ankur, Horsburgh, C. Robert, Freedberg, Kenneth A., Weinstein, Milton C., Paltiel, A. David, Reddy, Krishna P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517616/ https://www.ncbi.nlm.nih.gov/pubmed/37743931 http://dx.doi.org/10.1177/23814683231198873

Ejemplares similares

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus
por: Reddy, Krishna P, et al.
Publicado: (2020)

Rapid, point-of-care diagnosis of tuberculosis with novel Truenat assay: Cost-effectiveness analysis for India’s public sector
por: Lee, David J., et al.
Publicado: (2019)

2000. Rapid, Point-of-care Diagnosis of Tuberculosis with Novel Truenat Assay: Cost-Effectiveness and Budgetary Impact Analysis for India’s Public Sector
por: Lee, David J, et al.
Publicado: (2018)

Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for People Experiencing Sheltered Homelessness During the COVID-19 Pandemic
por: Baggett, Travis P., et al.
Publicado: (2020)

Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic
por: Baggett, Travis P., et al.
Publicado: (2020)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

798. Life-years Gained among non-Hispanic Black and White Men who have Sex with Men in the United States with Improvements in the HIV Care Continuum A Simulation Modeling Study
por: Rich, Katherine M, et al.
Publicado: (2022)

Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population
por: Reddy, Krishna P, et al.
Publicado: (2020)

Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
por: Walensky, Rochelle P., et al.
Publicado: (2016)

A Comparative Assessment of Non-Laboratory-Based versus Commonly Used Laboratory-Based Cardiovascular Disease Risk Scores in the NHANES III Population
por: Pandya, Ankur, et al.
Publicado: (2011)

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal
por: Losina, Elena, et al.
Publicado: (2009)

Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts
por: Neilan, Anne M, et al.
Publicado: (2020)

Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts
por: Neilan, Anne M., et al.
Publicado: (2020)

The Value of Sanocrysin Treatment in Pulmonary Tuberculosis
por: Benjamin, P. V.
Publicado: (1934)

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1
por: Linas, Benjamin P., et al.
Publicado: (2016)

Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe
por: Hyle, Emily P, et al.
Publicado: (2022)

HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
por: Sax, Paul E., et al.
Publicado: (2014)

The Value of Phrenic Exairesis in the Treatment of Pulmonary Tuberculosis
por: Benjamin, P. V.
Publicado: (1935)

Budget Impact of Medicaid Section 1115 Demonstrations for Early HIV Treatment
por: Schackman, Bruce R., et al.
Publicado: (2005)

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
por: Reddy, Krishna P., et al.
Publicado: (2020)

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
por: Reddy, Krishna P, et al.
Publicado: (2021)

Tuberculosis
por: Horsburgh, C. Robert
Publicado: (2014)

Superior Customer Value
por: Weinstein, Art
Publicado: (2016)

The implementation of change model adds value to value-based healthcare: a qualitative study
por: Zipfel, Nina, et al.
Publicado: (2019)

Projected Life Expectancy Gains From Improvements in HIV Care in Black and White Men Who Have Sex With Men
por: Rich, Katherine M., et al.
Publicado: (2023)

The Value of Models in Orthodontia
por: Watson, Milton T.
Publicado: (1904)

The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization
por: Kohli, Michele, et al.
Publicado: (2021)

The Value of Phrenic-Exairesis in the Treatment of Pulmonary Tuberculosis
por: Frimodt-Moller, C., et al.
Publicado: (1930)

The Value of Eucalyptus
por: Combie, F. C. P.
Publicado: (1911)

Some Observations on the Value of Iodine in Tuberculosis
por: Krishnamurty, Ch.
Publicado: (1927)

The Value of the Examination of Contacts in Pulmonary Tuberculosis
por: Banks, George S.
Publicado: (1937)

The value of laboratory tests in the diagnosis of tuberculosis
por: PETRE, NICOLAE, et al.
Publicado: (2017)

The Value of the Microscope in Diagnosis and Treatment of Tuberculosis
por: Price, J. Samuel
Publicado: (1892)

The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India
por: Zheng, Amy, et al.
Publicado: (2018)

Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis
por: Resch, Stephen C, et al.
Publicado: (2006)

The value of initial cavitation to predict re-treatment with pulmonary tuberculosis
por: Huang, Qiusheng, et al.
Publicado: (2016)

The Relative Value of Fillings
por: Pruyn, C. P.
Publicado: (1898)

Developing and Validating Metamodels of a Microsimulation Model of Infant HIV Testing and Screening Strategies Used in a Decision Support Tool for Health Policy Makers
por: Soeteman, Djøra I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_padn446j8mdgbl2b3fglegnltt